Burkitt lymphoma in African children: A priority for the global health agenda?
Corresponding Author
Raul C. Ribeiro MD
Department of Oncology, International Outreach Program, St. Jude Children's Research Hospital, Memphis, Tennessee
College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee
St. Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105.===Search for more papers by this authorJohn T. Sandlund MD
Department of Oncology, International Outreach Program, St. Jude Children's Research Hospital, Memphis, Tennessee
College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee
Search for more papers by this authorCorresponding Author
Raul C. Ribeiro MD
Department of Oncology, International Outreach Program, St. Jude Children's Research Hospital, Memphis, Tennessee
College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee
St. Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105.===Search for more papers by this authorJohn T. Sandlund MD
Department of Oncology, International Outreach Program, St. Jude Children's Research Hospital, Memphis, Tennessee
College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee
Search for more papers by this author
REFERENCES
- 1 Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958; 46: 218–223.
- 2
Kelly GL,
Rickinson AB.
Burkitt lymphoma: Revisiting the pathogenesis of a virus-associated malignancy.
Hematol Am Soc Hematol Educ Program
2007;
2007:
277–284.
10.1182/asheducation-2007.1.277 Google Scholar
- 3 Patte C, Auperin A, Michon J, et al. The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001; 97: 3370–3379.
- 4 Sandlund JT, Fonseca T, Leimig T, et al. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil. Leukemia 1997; 11: 743–746.
- 5 Acquatella G, Insausti CL, Garcia R, et al. Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol. Pediatr Blood Cancer 2004; 43: 580–586.
- 6 Workman GM, Ribeiro RC, Rai SN, et al. Pediatric cancer knowledge: Assessment of knowledge of warning signs and symptoms for pediatric cancer among Brazilian community health workers. J Cancer Educ 2007; 22: 181–185.
- 7 Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004; 291: 2471–2475.
- 8 Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer 2007; 49: 941–946.
- 9 Howard SC, Ortiz R, Baez LF, et al. Protocol-based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)—Part II. Pediatr Blood Cancer 2007; 48: 486–490.
- 10 Committee on Cancer Control in Low- and Middle-Income Countries, Board on Global Health. Cancer control opportunities in low-and middle-income countries. Washington, D.C.: The National Academies Press; 2007.
